Skip to main content

Idera Pharmaceuticals is a clinical stage biotechnology company with expertise in discovering, developing and commercializing novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. Idera is focused on harnessing the potential of our proprietary technology to treat genetically defined forms of B-cell lymphomas and rare autoimmune diseases. Learn More

Clinical Trials

Idera is advancing to the clinic in genetically defined forms of B-cell lymphoma: activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL) and Waldenström’s macroglobulinemia.

Learn More

TLR structure” by The cat, used under GNU Free Documentation License / Cropped and colored background from original.